BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giske CG, Borén C, Wretlind B, Kronvall G. Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA. Clin Microbiol Infect 2005;11:662-9. [PMID: 16008620 DOI: 10.1111/j.1469-0691.2005.01182.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kronvall G, Smith P. Normalized resistance interpretation, the NRI method: Review of NRI disc test applications and guide to calculations. APMIS 2016;124:1023-30. [PMID: 27859688 DOI: 10.1111/apm.12624] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
2 Kronvall G. Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints. J Clin Microbiol 2010;48:4445-52. [PMID: 20926714 DOI: 10.1128/JCM.01101-10] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
3 Kronvall G. Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development: ANTIMICROBIAL RESISTANCE 1979-2009 IN STOCKHOLM. APMIS 2010;118:621-39. [DOI: 10.1111/j.1600-0463.2010.02660.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
4 Giske CG, Buarø L, Sundsfjord A, Wretlind B. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microb Drug Resist 2008;14:23-30. [PMID: 18321207 DOI: 10.1089/mdr.2008.0778] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
5 Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathol Biol (Paris) 2009;57:530-5. [PMID: 18977099 DOI: 10.1016/j.patbio.2008.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
6 Dreier J, Ruggerone P. Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Front Microbiol 2015;6:660. [PMID: 26217310 DOI: 10.3389/fmicb.2015.00660] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 11.6] [Reference Citation Analysis]
7 Wolter DJ, Khalaf N, Robledo IE, Vázquez GJ, Santé MI, Aquino EE, Goering RV, Hanson ND. Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases. Antimicrob Agents Chemother 2009;53:1660-4. [PMID: 19188398 DOI: 10.1128/AAC.01172-08] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
8 Rodríguez M, Ruiz del Castillo B, Rodríguez-mirones C, Romo M, Monteagudo I, Martínez-martínez L. Caracterización molecular de aislados clínicos de Pseudomonas aeruginosa productores de la metalobetalactamasa VIM-2 en Cantabria, España. Enfermedades Infecciosas y Microbiología Clínica 2010;28:99-103. [DOI: 10.1016/j.eimc.2009.01.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
9 Baum EZ, Crespo-Carbone SM, Morrow BJ, Davies TA, Foleno BD, He W, Queenan AM, Bush K. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53:2785-90. [PMID: 19433554 DOI: 10.1128/AAC.00018-09] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
10 Rodrigues A, Gomes A, Marçal PH, Dias-Souza MV. Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa. J Adv Res 2017;8:55-61. [PMID: 28053782 DOI: 10.1016/j.jare.2016.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]